Detalhe da pesquisa
1.
A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy.
Mov Disord
; 35(11): 1957-1965, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32882100
2.
Effects of single and combined immunotherapy approach targeting amyloid ß protein and α-synuclein in a dementia with Lewy bodies-like model.
Alzheimers Dement
; 15(9): 1133-1148, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31378574
3.
Active immunization therapies for Parkinson's disease and multiple system atrophy.
Mov Disord
; 31(2): 214-24, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260853
4.
Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.
Acta Neuropathol
; 127(6): 861-79, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24525765
5.
Pyroglutamylated amyloid-ß is associated with hyperphosphorylated tau and severity of Alzheimer's disease.
Acta Neuropathol
; 128(1): 67-79, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24861310
6.
3D Screen Printing Offers Unprecedented Anticounterfeiting Strategies for Oral Solid Dosage Forms Feasible for Large Scale Production.
Pharmaceutics
; 16(3)2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543262
7.
3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles.
Int J Pharm
; 642: 123101, 2023 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295568
8.
Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNA.
Mol Ther Nucleic Acids
; 33: 642-654, 2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650117
9.
Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression.
Pharmaceutics
; 14(1)2022 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35057047
10.
3D screen printing - An innovative technology for large-scale manufacturing of pharmaceutical dosage forms.
Int J Pharm
; 592: 120096, 2021 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217548
11.
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 Study.
J Parkinsons Dis
; 11(3): 1079-1089, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092654
12.
Self-assembly of differentiated progenitor cells facilitates spheroid human skin organoid formation and planar skin regeneration.
Theranostics
; 11(17): 8430-8447, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373751
13.
AFFITOME® technology in neurodegenerative diseases: the doubling advantage.
Hum Vaccin
; 6(11): 948-52, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20980801
14.
Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial.
Lancet Neurol
; 19(7): 591-600, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32562684
15.
Perforating folliculitis, angioedema, hand-foot syndrome--multiple cutaneous side effects in a patient treated with sorafenib.
J Dtsch Dermatol Ges
; 7(5): 449-52, 2009 May.
Artigo
em Inglês, Alemão
| MEDLINE | ID: mdl-19178612
16.
Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer.
Sci Rep
; 8(1): 12954, 2018 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30154486
17.
The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
Haematologica
; 91(3): 405-8, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16531267
18.
IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient.
J Dtsch Dermatol Ges
; 4(12): 1045-50, 2006 Dec.
Artigo
em Inglês, Alemão
| MEDLINE | ID: mdl-17176412
19.
Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.
Melanoma Res
; 15(6): 523-9, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16314738
20.
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Mol Neurodegener
; 10: 10, 2015 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25886309